1. Home
  2. CRVS vs NL Comparison

CRVS vs NL Comparison

Compare CRVS & NL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRVS
  • NL
  • Stock Information
  • Founded
  • CRVS 2014
  • NL 1891
  • Country
  • CRVS United States
  • NL United States
  • Employees
  • CRVS N/A
  • NL N/A
  • Industry
  • CRVS Biotechnology: Pharmaceutical Preparations
  • NL Major Chemicals
  • Sector
  • CRVS Health Care
  • NL Industrials
  • Exchange
  • CRVS Nasdaq
  • NL Nasdaq
  • Market Cap
  • CRVS 305.4M
  • NL 316.5M
  • IPO Year
  • CRVS 2016
  • NL N/A
  • Fundamental
  • Price
  • CRVS $4.10
  • NL $5.61
  • Analyst Decision
  • CRVS Strong Buy
  • NL Sell
  • Analyst Count
  • CRVS 4
  • NL 1
  • Target Price
  • CRVS $15.00
  • NL $6.00
  • AVG Volume (30 Days)
  • CRVS 445.0K
  • NL 38.0K
  • Earning Date
  • CRVS 08-12-2025
  • NL 08-06-2025
  • Dividend Yield
  • CRVS N/A
  • NL 5.83%
  • EPS Growth
  • CRVS N/A
  • NL 441.25
  • EPS
  • CRVS N/A
  • NL 1.25
  • Revenue
  • CRVS N/A
  • NL $148,242,000.00
  • Revenue This Year
  • CRVS N/A
  • NL $15.75
  • Revenue Next Year
  • CRVS N/A
  • NL $2.44
  • P/E Ratio
  • CRVS N/A
  • NL $4.95
  • Revenue Growth
  • CRVS N/A
  • NL N/A
  • 52 Week Low
  • CRVS $2.47
  • NL $5.21
  • 52 Week High
  • CRVS $10.00
  • NL $9.42
  • Technical
  • Relative Strength Index (RSI)
  • CRVS 44.93
  • NL 30.15
  • Support Level
  • CRVS $4.58
  • NL $6.35
  • Resistance Level
  • CRVS $4.98
  • NL $6.72
  • Average True Range (ATR)
  • CRVS 0.23
  • NL 0.37
  • MACD
  • CRVS -0.04
  • NL -0.05
  • Stochastic Oscillator
  • CRVS 13.79
  • NL 12.03

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

About NL NL Industries Inc.

NL Industries Inc is a holding company that operates in the component products industry. Through its subsidiary, it manufactures engineered components that are sold to a range of industries, including recreational transportation, postal, office and institutional furniture, cabinetry, tool storage, healthcare, gas stations and vending equipment. It also produces a precision ball bearing slide, security products, and ergonomic computer support systems. The company derives majority of its revenue from Europe.

Share on Social Networks: